Karen Koski analyst

Currently out of the existing stock ratings of Karen Koski, 6 are a HOLD (60%), 1 are a SELL (10%), 3 are a BUY (30%).

Karen Koski

Work Performance Price Targets & Ratings Chart

Analyst Karen Koski works with a stock forecast success ratio of 83.33% fulfilled within 193 days on average.

Karen Koski’s has documented 15 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AXDX, Accelerate Diagnostics at 08-Oct-2020.

Wall Street Analyst Karen Koski

Analyst best performing recommendations are on AXDX (ACCELERATE DIAGNOSTICS).
The best stock recommendation documented was for AXDX (ACCELERATE DIAGNOSTICS) at 8/9/2016. The price target of $260 was fulfilled within 36 days with a profit of $40 (18.18%) receiving and performance score of 5.05.

Average potential price target upside

TTOO T2 Biosystms AXDX Accelerate Diagnostics

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

12

$9.18 (325.53%)

20

9 months 8 days ago

4/4 (100%)

$0.87 (7.82%)

23

Hold

7500

1 years 9 months 15 days ago

3/5 (60%)

$3649 (94.75%)

390

Buy

15000

3 years 5 months 17 days ago

1/1 (100%)

$7050 (88.68%)

177

Hold

200

$194.55 (3569.72%)

200

6 years 11 months 14 days ago

2/3 (66.67%)

$64.67 (8.94%)

172

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Karen Koski?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?